Abeona Therapeutics, Inc.

Stock ticker:

Shares of Abeona Therapeutics plunged more than 45% in early morning trading on April 23 after the Company disclosed receiving a Complete Response Letter from the U.S. Food and Drug Administration for its lead clinical program pz-cel.

Download Complaint

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.